There was no significant statistical relationship between positive/high expression of HER2 and a series of clinical characteristics including gender, high, middle and low differentiation, tumor stage, vascular invasion, nerve invasion, Lymph node metastasis, T stage and pathological type of patients with biliary tract carcinoma. This evidence concerns the gene ERBB2 and neoplasm.